Wockhardt's Daman plant GMP compliant: UK MHRA

"UK MHRA (The Medicines and Healthcare products Regulatory Agency) has since confirmed that our manufacturing unit at Kadaiya Daman complies with the principles and guidelines of good manufacturing practices," Wockhardt said in a regulatory filing.

December 13, 2016 / 21:31 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Drug firm Wockhardt today said the UK health regulator has confirmed that its Daman-based manufacturing facility complies with good manufacturing practices (GMP).

"UK MHRA (The Medicines and Healthcare products Regulatory Agency) has since confirmed that our manufacturing unit at Kadaiya Daman complies with the principles and guidelines of good manufacturing practices," Wockhardt said in a regulatory filing.

In view of this, the approval status of the said unit continues, it added.

Shares of Wockhardt today ended at Rs 690.15 apiece on BSE, up 0.32 percent from previous close.

first published: Dec 13, 2016 07:32 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347